The U.S. is having its worst year for measles in more than three decades
The U.S. Centers for Disease Control and Prevention said Wednesday that the national case count surpassed 2019, when there were 1,274 cases for the year and the country almost lost its status of having eliminated the vaccine-preventable illness. That could happen this year if the virus has nonstop spread for 12 months.
This year's outbreaks, some of them interconnected, started five months ago in undervaccinated communities in West Texas. Three people have died — two children in Texas and an adult in New Mexico — and dozens of people have been hospitalized. Public health experts maintain the true case count may be higher than state health departments have confirmed.
North America has three other major measles outbreaks, with 2,966 cases in Chihuahua state, Mexico, 2,223 cases in Ontario, Canada and 1,230 in Alberta, Canada. Twelve other states have current confirmed outbreaks of three or more people — Arizona, Colorado, Georgia, Illinois, Iowa, Kansas, Michigan, Montana, New Mexico, North Dakota, Oklahoma and Utah — and four other states saw their outbreaks end.
The measles, mumps and rubella vaccine is 97% effective at preventing measles after two doses.
The World Health Organization said in 2000 that measles had been eliminated from the U.S.
The CDC identified 22 outbreaks in 2019, the largest being two separate clusters in New York — 412 in New York state and 702 in New York City. These were linked because as measles was spreading through close-knit Orthodox Jewish communities, the CDC said.
It's a similar situation in North America this year, where the Canada, Mexico and Texas outbreaks stem from large Mennonite communities in the regions. Mennonite churches do not formally discourage vaccination, though more conservative Mennonite communities historically have low vaccination rates and a distrust of government.
A recent study found childhood vaccination rates against measles fell after the COVID-19 pandemic in nearly 80% of the more than 2,000 U.S. counties with available data, including in states that are battling outbreaks this year.
Only 92.7% of kindergarteners in the U.S. had the measles, mumps and rubella vaccine in the 2023-2024 school year, below the 95% needed to prevent outbreaks. In Gaines County, Texas, the epicenter of the Texas outbreak, only 82% of kindergarteners were up-to-date with MMR vaccines.
State and federal leaders have for years kept funding stagnant for local public health departments' vaccination programs that are tasked with reversing the trend.
'What we're seeing with measles is a little bit of a 'canary in a coal mine,'' said Lauren Gardner, leader of Johns Hopkins University's independent measles and COVID tracking databases. 'It's indicative of a problem that we know exists with vaccination attitudes in this county and just, I think, likely to get worse.'
Shastri writes for the Associated Press. The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
San Francisco Chronicle
24 minutes ago
- San Francisco Chronicle
FDA names former pharmaceutical company executive to oversee US drug program
WASHINGTON (AP) — The Food and Drug Administration on Monday named a longtime pharmaceutical executive to run the agency's drug program, the latest in a string of leadership changes at the agency. FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency's Center for Drug Evaluation and Research, which regulates the safety and effectiveness of all U.S. drugs. His appointment comes a month after the center's acting director, Dr. Jacqueline Corrigan-Curay, announced her retirement. As the agency's top drug regulator, Tidmarsh will be charged with following through on a number of commitments made by Makary and his boss, Health Secretary Robert F. Kennedy Jr., including reviewing the safety of the abortion pill mifepristone. The FDA is also scrutinizing certain uses of other long-established drugs, including antidepressants and hormone-replacement drugs for menopause. Tidmarsh founded and led several pharmaceutical companies, including Horizon Pharmaceuticals, maker of an anti-inflammatory medication for arthritis. He has also served as an adjunct professor at Stanford University. The FDA's drug center is the agency's largest unit, with nearly 6,000 staffers responsible for reviewing the safety and effectiveness of new drugs and monitoring the use and marketing of older drugs. About 2,000 FDA staffers have been laid off as part of widescale cuts to the federal health workforce overseen by Kennedy. More than 1,000 others have taken buyouts or early retirement, while many others are reportedly searching for new jobs. The departures have threatened basic FDA operations, including the timely review of new drugs. Nearly all of the FDA's senior leadership positions have turned over in recent months, either due to retirements, resignations or actions by administration officials placing them on administrative leave. FDA center directors typically hold their positions for years or even decades, serving across multiple administrations, whether Republican or Democrat. In May, Makary named Dr. Vinay Prasad, a prominent critic of the FDA's COVID response, to run the agency's vaccine center. He was also named to the post of FDA chief medical officer. Prasad joined the agency after his predecessor, longtime vaccine chief Dr. Peter Marks, was forced out in March. The head of FDA's tobacco center was also forced to step down in April. A permanent replacement has not yet been named. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Hamilton Spectator
38 minutes ago
- Hamilton Spectator
Veteran Global Health Leader, Dr. Rebecca Martin, Named President of Global Immunization at Sabin
WASHINGTON, July 21, 2025 (GLOBE NEWSWIRE) — Renowned global health expert Rebecca Martin, PhD, recognized internationally for her leadership in developing and implementing immunization programs and strengthening health systems, joins the Sabin Vaccine Institute today as President of Global Immunization, assuming the reins of the nonprofit's efforts in vaccination innovation and extending vaccine access. Martin most recently served as Vice President for Global Health at Emory University, and as the Director of the Emory Global Health Institute, following a 24-year career with the US Centers for Disease Control and Prevention (CDC). She is also an adjunct professor in the Department of Global Health at Emory. She brings decades of successful partnering with global, regional and country-level health leaders in infectious disease prevention, as well as in-country experience leading low- and middle-income country (LMIC) health and immunization initiatives. Her extensive CDC career includes ten years working in Kenya, Tanzania, and Denmark, seconded to the World Health Organization African and European regions. In her four years in Nairobi, Kenya, she provided technical expertise to eight East African countries focused on vaccine-preventable disease surveillance, prevention and elimination strategies and policies, and new vaccine introductions. For several years in Dar as Salaam, Tanzania, she led surveillance and workforce development for CDC as part of the President's Emergency Plan for AIDS Relief (PEPFAR), and supervised staff in surveillance, health management information systems (HMIS), monitoring and evaluation (M&E), and human capacity development for CDC HIV/AIDS programs. Currently, she serves as the Vice-Chair for WHO Regional Office for Africa (AFRO) Emergency Preparedness & Response Technical Advisory Group (EPR-TAG), an independent advisory group providing strategic guidance on all matters pertaining to public health emergency preparedness and response in Africa. 'With her global, country and local-level experience, Rebecca has the first-hand expertise needed to address today's challenging immunization landscape, and more importantly, to co-create new solutions with public and private partners to boost lagging immunization rates and prevent human suffering,' says Sabin CEO Amy Finan. 'She is an outstanding addition to Sabin's executive team and will lead Sabin's global immunization work as we continue to respond to the needs of individual countries and help shape new global strategies with partners to increase access and uptake of vaccines.' Martin calls her new role a 'full circle' moment. 'I am honored and excited to join the Sabin Vaccine Institute as President of Global Immunization, bringing my experience, knowledge, and commitment to Sabin's critical mission in making vaccines available to everyone, everywhere,' she says. 'I am thrilled to work with the dedicated colleagues at Sabin who are passionate about tackling vaccine-preventable diseases through collaboration with stakeholders from multiple sectors in addition to health,' she adds. 'There is no moment more urgent than now to innovate and double down on our efforts to prevent illness and save lives through immunization.' Sabin's Global Immunization team works with local and national governments and academic, global, and philanthropic partners to put communities at the heart of solutions that tackle urgent vaccination challenges, with a renewed focus to bolster the falling coverage in childhood routine immunization and support life-course immunization. In 2023, almost 14.5 million children received no vaccinations, according to WHO, an increase of 2.7 million more children compared to 2019. The Sabin team brings expertise across the immunization spectrum, including building global communities of practice, identifying barriers and creating solutions to improve vaccine access and delivery of current and new vaccines, and conducting epidemiological research to support immunization. Sabin's skills are applied to multiple infectious diseases, including HPV, typhoid, cholera, rotavirus, COVID-19 and malaria. Additional work includes efforts to immunize zero-dose children and transition to hexavalent vaccines in national immunization programs. During her tenure at Emory, Martin built and aligned multidisciplinary global health infrastructure, fostered global collaborations across health organizations, led interdisciplinary global health research and worked to build the next generation of global health leaders. She was also a member of Emory's Woodruff Health Sciences Center leadership team. Martin's most recent role with the CDC was Director of the Center for Global Health, then the largest operating unit at the CDC. Her achievements include leading the CDC's global efforts across disease initiatives and through the start of the global health security agenda, including polio eradication and disease control acceleration and elimination for vaccine-preventable diseases, malaria elimination, ending HV epidemics, and strengthening health systems to detect and respond to disease threats and emergencies. Martin received her Doctor of Philosophy from the Johns Hopkins Bloomberg School of Public Health in international health with a focus on infectious disease epidemiology. She has co-authored manuscripts and developed strategic plans, normative guidance and guidelines on immunization strategies, vaccine-preventable diseases and surveillance methods for both immunization and HIV, and for global health security. About the Sabin Vaccine Institute The Sabin Vaccine Institute is a leading advocate for expanding vaccine access and uptake globally, advancing vaccine research and development, and amplifying vaccine knowledge and innovation. Unlocking the potential of vaccines through partnership, Sabin has built a robust ecosystem of funders, innovators, implementers, practitioners, policy makers and public stakeholders to advance its vision of a future free from preventable diseases. As a nonprofit with three decades of experience, Sabin is committed to finding solutions that last and extending the full benefits of vaccines to all people, regardless of who they are or where they live. At Sabin, we believe in the power of vaccines to change the world. For more information, visit and follow us on X @SabinVaccine. Media Contact: Monika Guttman Senior Media Relations Specialist Sabin Vaccine Institute +1 (202) 621-1691 press@ A photo accompanying this announcement is available at
Yahoo
3 hours ago
- Yahoo
Fitness classes help elderly Ugandan women fight rising rates of obesity and diabetes
Fitness classes help elderly Ugandan women fight rising rates of obesity and diabetes JINJA, Uganda (Reuters) -Wearing floor-length dresses and wrap-around skirts, the group of elderly women giggle and tease each other as they jog in pairs, hand in hand, across a playing field in Kivubuka, a village in eastern Uganda. The exercise class is part of a project aimed at reducing increasing rates of noncommunicable diseases such as hypertension, diabetes and heart disease and has attracted more than 1,000 people since it began five years ago. While famine and malnutrition remain major concerns in several African countries, obesity is increasingly on the march, especially among Ugandan women. Jane Anonyaalaba, a grandmother, is one of those looking to buck the trend. She used to struggle with high blood pressure, persistent aches and occasional paralysis in her limbs. "I would breathe with difficulty. Climbing a hill was almost impossible," the 70-year-old said. Now, she bends over double to whack three tennis balls with a cricket bat before running between a set of blue plastic wickets. A quarter of a century ago, just 4% of Ugandan women were obese, but that figure had more than doubled to 10.4% by 2019, according to the latest available dataset provided by the Global Nutrition Report, which tracks global nutrition. By comparison, male obesity had risen to just 2.3%. Weekly fitness clubs like Kivubuka may be a model for a local, low-cost approach to supporting aging communities across Africa, where 17% of adult women and 6.8% of men are obese. As people lead more urban, sedentary lifestyles, and eat cheaper ultra-processed foods, the continent is becoming more obese, according to the World Health Organization (WHO). Obesity has brought a corollary rise in deaths: around one-third of Ugandans died from NCDs in 2016, almost double the number in 2000. "I want to think and believe that there (has been) a change in their lives," said Isaac Imaka, who organises the club on behalf of the Gabula Royal Foundation, a charity established by a Ugandan traditional leader. "This... is a place where you can come and find a new friend, and just have something to talk about." Solve the daily Crossword
